Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-25 @ 4:01 AM
NCT ID:
NCT03375502
Brief Summary:
To assess the safety of MG1111 and to evaluate immunological non-inferiority of MG1111 versus comparator
Study:
NCT03375502
Study Brief:
Protocol Section:
NCT03375502